Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction

被引：93
|
作者：
Bertrand, Helene C. [1 ]
Schaap, Marjolein [1 ]
Baird, Liam [2 ]
Georgakopoulos, Nikolaos D. [1 ]
Fowkes, Adrian [1 ]
Thiollier, Clarisse [1 ]
Kachi, Hiroko [1 ]
Dinkova-Kostova, Albena T. [2 ,3 ,4 ]
Wells, Geoff [1 ]
机构：
[1] UCL, UCL Sch Pharm, London WC1N 1AX, England
[2] Univ Dundee, Med Res Inst, Div Canc Res, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Scotland
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 18期
基金：
英国生物技术与生命科学研究理事会;
关键词：
RANDOMIZED CLINICAL-TRIAL; OXIDATIVE STRESS; PEPTIDE INHIBITORS; NRF2-KEAP1; COMPLEX; KELCH DOMAIN; DLG MOTIFS; BINDING; PATHWAY; UBIQUITINATION; DISCOVERY;
D O I：
10.1021/acs.jmedchem.5b00602
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The transcription factor Nrf2 regulates the expression of a large network of cytoprotective and metabolic enzymes and proteins. Compounds that directly and reversibly inhibit the interaction between Nrf2 and its main negative regulator Keap1 are potential pharmacological agents for a range of disease types including neurodegenerative conditions and cancer. We describe the development of a series of 1,4-dipheny1-1,2,3-triazole compounds that inhibit the Nrf2-Keap1 protein protein interaction (PPI) in vitro and in live cells and up-regulate the expression of Nrf2-dependent gene products.
引用
收藏
页码：7186 / 7194
页数：9
相关论文
共 50 条
  • [41] Screening of phytochemicals against KEAP1-NRF2 interaction to reactivate NRF2 Functioning: Pharmacoinformatics based approach
    Akmal, Arina
    Javaid, Anam
    Hussain, Riaz
    Kanwal, Asma
    Zubair, Muhammad
    Ashfaq, Usman Ali
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 33 (06) : 2823 - 2828
  • [42] Structure-Activity and Structure-Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1-Nrf2 Protein-Protein Interaction Inhibitor
    Jiang, Zheng-Yu
    Xu, Li-Li
    Lu, Meng-Chen
    Chen, Zhi-Yun
    Yuan, Zhen-Wei
    Xu, Xiao-Li
    Guo, Xiao-Ke
    Zhang, Xiao-Jin
    Sun, Hao-Peng
    You, Qi-Dong
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (16) : 6410 - 6421
  • [43] Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction
    Begnini, Fabio
    Geschwindner, Stefan
    Johansson, Patrik
    Wissler, Lisa
    Lewis, Richard J.
    Danelius, Emma
    Luttens, Andreas
    Matricon, Pierre
    Carlsson, Jens
    Lenders, Stijn
    Konig, Beate
    Friedel, Anna
    Sjoe, Peter
    Schiesser, Stefan
    Kihlberg, Jan
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 3473 - 3517
  • [44] Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury
    Hui, Qiaoyan
    Karlstetter, Marcus
    Xu, Zhenhua
    Yang, Jing
    Zhou, Lingli
    Eilken, Hanna M.
    Terjung, Carsten
    Cho, Hongkwan
    Gong, Junsong
    Lai, Michael J.
    Nassar, Khaled
    Duh, Elia J.
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 146 : 181 - 188
  • [45] An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis
    Lu, Meng-Chen
    Ji, Jian-Ai
    Jiang, Yong-Lin
    Chen, Zhi-Yun
    Yuan, Zhen-Wei
    You, Qi-Dong
    Jiang, Zheng-Yu
    SCIENTIFIC REPORTS, 2016, 6
  • [46] Discovery of benzo[g]indoles as a novel class of non-covalent Keap1-Nrf2 protein-protein interaction inhibitor
    Yasuda, Daisuke
    Yuasa, Akihiro
    Obata, Rika
    Nakajima, Mao
    Takahashi, Kyoko
    Ohe, Tomoyuki
    Ichimura, Yoshinobu
    Komatsu, Masaaki
    Yamamoto, Masayuki
    Imamura, Riyo
    Kojima, Hirotatsu
    Okabe, Takayoshi
    Nagano, Tetsuo
    Mashino, Tadahiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (22) : 5006 - 5009
  • [47] Development of a steady-state FRET-based assay to identify inhibitors of the Keap1-Nrf2 protein-protein interaction
    Schaap, Marjolein
    Hancock, Rowena
    Wilderspin, Andrew
    Wells, Geoff
    PROTEIN SCIENCE, 2013, 22 (12) : 1812 - 1819
  • [48] An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis
    Meng-Chen Lu
    Jian-Ai Ji
    Yong-Lin Jiang
    Zhi-Yun Chen
    Zhen-Wei Yuan
    Qi-Dong You
    Zheng-Yu Jiang
    Scientific Reports, 6
  • [49] Novel Hydrogen Sulfide Hybrid Derivatives of Keap1-Nrf2 Protein-Protein Interaction Inhibitor Alleviate Inflammation and Oxidative Stress in Acute Experimental Colitis
    Zhang, Xian
    Cui, Keni
    Wang, Xiaolu
    Tong, Yuanyuan
    Liu, Chihong
    Zhu, Yuechao
    You, Qidong
    Jiang, Zhengyu
    Guo, Xiaoke
    ANTIOXIDANTS, 2023, 12 (05)
  • [50] Emerging Screening Approaches in the Development of Nrf2-Keap1 Protein-Protein Interaction Inhibitors
    Leung, Chung-Hang
    Zhang, Jia-Tong
    Yang, Guan-Jun
    Liu, Hao
    Han, Quan-Bin
    Ma, Dik-Lung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
12345